START FREE TRIAL

Technology & AI

The REAL Risk In NVIDIA Isn’t AI — It’s Washington!

The artificial intelligence boom has turned one company into the world’s most important...

Oracle Just EXPOSED The Hidden Infrastructure Problem Behind AI!

The artificial intelligence boom has a familiar story. Demand is exploding. Tech giants...

Is Apple’s $599 Strategy About Price… Or A Bigger Ecosystem SHIFT?

When people think of Apple Inc. (NASDAQ:AAPL), the word “cheap” rarely comes to...

M&A

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong...

Is Eli Lilly’s Orna Acquisition About RNA Or Something MUCH BIGGER?

Eli Lilly’s move to acquire Orna Therapeutics landed quietly, framed as another pipeline...

Is Apple Outflanking Meta With This Q.AI Move?

Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around...

Consumer & Retail

Lululemon’s Proxy Battle Looks Tactical, But It’s STRATEGIC

The battle inside Lululemon (NASDAQ:LULU) just escalated. Founder Chip Wilson has moved from...

Did Papa John’s Just Signal RETREAT, Not A REAL Turnaround?

When Papa John’s International (NASDAQ:PZZA) announced it would close 300 U.S. stores by...

Carvana’s Selloff Isn’t Just Noise—It’s A Warning Sign

The latest pullback in Carvana (NYSE:CVNA) has been framed by some as a...

Premium

Why $100 Oil May Not Mean What Investors Think For Oil Majors & Airlines!

Oil markets have entered one of their most volatile periods in years. Crude...

The REAL Risk In NVIDIA Isn’t AI — It’s Washington!

The artificial intelligence boom has turned one company into the world’s most important...

Oracle Just EXPOSED The Hidden Infrastructure Problem Behind AI!

The artificial intelligence boom has a familiar story. Demand is exploding. Tech giants...

Healthcare

Qiagen Just Dropped Two Magic Words—And Wall Street Heard “Buyout”

Qiagen (NYSE:QGEN) just did the thing companies do right before Wall Street starts...

Is Merck’s HIV Win Really About Keytruda?

When Merck & Co. (NYSE:MRK) reported Phase 3 data showing its two-drug HIV...

Did Novo Nordisk’s Trial Miss Just Hand Lilly The Edge?

It has been a bruising few weeks for Novo Nordisk (NYSE:NVO). First came...

Energy

Is Chevron’s Iraq Deal A Win — Or A Twelve-Month Test With Hidden Friction?

Chevron (NYSE:CVX) just slid into the driver’s seat for one of Iraq’s crown-jewel...

ConocoPhillips Just Pruned $2B Of Permian Assets—Discipline Or HIDDEN RISK?

When ConocoPhillips (NYSE:COP) explores selling roughly $2 billion of Delaware Basin assets, it...

U.S. Gas Prices Are Sliding—THESE Stocks Tell A Different Story!

U.S. natural gas prices have slipped into a different regime faster than many...

Industrials

BorgWarner’s AI Pivot Is Powering A Re-Rating — But Where Could The Story Crack?

BorgWarner has quietly engineered one of the more dramatic sentiment reversals in the...

Did The Rio Tinto–Glencore Deal Fail Because Copper Is TOO Strategic?

Rio Tinto and Glencore walked away from merger talks that would have reshaped...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace...

Miscellaneous

Why $100 Oil May Not Mean What Investors Think For Oil Majors & Airlines!

Oil markets have entered one of their most volatile periods in years. Crude...

Is DraftKings Copying Its Sports-Betting Playbook, Or Building A Kalshi-Killer?

DraftKings (NASDAQ:DKNG) is making a very “DraftKings” move: take a new format, tuck...

Are You Buying The Wrong “War Basket” While The Second Trade Forms?

The U.S.–Israel–Iran conflict has shifted from a regional headline to a global risk...